Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Publicly accessible evidence of health-related quality of life benefits associated with cancer drugs approved by the European Medicines Agency between 2009 and 2015.
Eur J Cancer. 2020 Apr;129:23-31. doi: 10.1016/j.ejca.2020.01.020. Epub 2020 Feb 28.
Eur J Cancer. 2020.
PMID: 32120272
Free article.
Twelve years of European cancer drug approval-a systematic investigation of the 'magnitude of clinical benefit'.
Grössmann N, Wolf S, Rothschedl E, Wild C.
Grössmann N, et al. Among authors: rothschedl e.
ESMO Open. 2021 Jun;6(3):100166. doi: 10.1016/j.esmoop.2021.100166. Epub 2021 Jun 1.
ESMO Open. 2021.
PMID: 34087744
Free PMC article.
Item in Clipboard
Coronary Sinus Reducing Stent for the Treatment of Refractory Angina Pectoris: A Health Technology Assessment.
Stanak M, Rothschedl E, Szymanski P.
Stanak M, et al. Among authors: rothschedl e.
Med Devices (Auckl). 2020 Sep 16;13:259-276. doi: 10.2147/MDER.S255440. eCollection 2020.
Med Devices (Auckl). 2020.
PMID: 32982492
Free PMC article.
Review.
Item in Clipboard
Cite
Cite